..................................................
I will delete posts that are
solicitation from a pump site
or solicitation of us by salesmen
..................................................
$NEXCF at resistance $0.88
OTC/QB avg daily volume (low) 16k website hold x 100% sell filings and news 3/27/2020
$6 million in Revenues Period Ended December 31st 2019
$SHMP looking for a bottom $0.027
OTC/QB - made a ton of money the 1st run ($0.02)
Avg daily Volume 440k
Now looking for a bottom play re entry. A Game Changer stock.
Perfected clean "farming" of salt water shrimp and fish. Website float 300.64m
100% sell filings and news 3/18/20 a fire has destroyed the main building
Note:
We are adopting a policy
of barring and deleting paid humps and the like !!
I will delete any paid promo. They come here to make
some use of our casual stock sharing environment.
Good riddance.
Sign in the entrance window:
We will also delete any so-called market research
advertisement or any post fronting such off-site and
any off-site email sign-up or company solicitation.
< All foreign exchange stocks are welcome so long
as their exchange is clearly shown each posting.
A word to the wise:
"Stock picking is work".
"The stock market
is all about work."
"Just you and it "
We follow stocks with a low float < 100M
and stocks with an ultra low float < 30M.
But whatever is moving well, makes a1list.
Charts qualify that are looking up in some way:
on a moving average at resistance or support,
or with a staging formation such as a bull flag.
An upgrading Pr is great too.
The float shown is the highest number
from OTCMarkets-YahooFinance-WSJournal.
I use the highest of any two I look at.
Re: O/S Checked against SEC filings.
Microfluidics Market Overview The global microfluidics market, valued at approximately USD 21.36 billion, is set for impressive growth. Predictions suggest it will reach about USD 32.67 billion by the end of 2029. This significant expansion is a clear indicator of the transformation occurring within diagnostics, life sciences, and pharmaceutical research. Driving Forces...
The Incredible Growth of Primerica Primerica (NYSE: PRI) has truly left a mark in the financial sector, showcasing remarkable performance over the last decade. With an annualized return of 17.97%, it has outperformed the market by 7.08%, demonstrating its strong foundational growth and investment appeal. As of now, Primerica holds a market capitalization of $9.18 billion,...
Illumina and MyOme Collaboration Overview Illumina has recently entered into a significant collaboration deal with MyOme, a company specializing in genomic analysis. This partnership isn't just a strategic investment; it's an aerospace-like synergy aimed at transforming how healthcare operates in the United States. With a bold vision, the duo is set to explore innovative...
BlackSky Technology Gains Momentum After Major Contract Win BlackSky Technology Inc (BKSY) has seen its shares trade higher recently thanks to the remarkable announcement of a five-year contract with the U.S. National Geospatial-Intelligence Agency (NGA). This contract, valued at up to $290 million, will enable BlackSky to leverage its advanced satellite monitoring...
BioXcel Therapeutics: AI in Medicine BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is making waves in the biopharmaceutical sector using artificial intelligence (AI) to forge new paths in neuroscience medication. The CEO, Vimal Mehta, Ph.D., will take the stage at the highly regarded Canaccord Genuity 45th Annual Growth Conference. This pivotal event will take place in...
